Target Essentiality and Centrality Characterize Drug Side Effects

PLoS Computational Biology

Volumn 9, Issue 7, 2013, Pages

  Wang, Xiujuan ^a,b   Thijssen, Bram ^c   Yu, Haiyuan ^a,b  

^a Plant Science Building   (United States)

^b School of Integrative Plant Sciences   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC-RESOLUTION; BETWEENNESS; DRUG SIDE-EFFECTS; DRUG TARGETS; HUMAN PROTEINS; INTERACTION INTERFACE; INTERACTION NETWORKS; PROTEIN TARGETS; SIDE EFFECT; THREE-DIMENSIONAL INTERACTION;

DRUG INTERACTIONS;

NUTRACEUTICAL; PROTEIN;

ADVERSE DRUG REACTION; ARTICLE; DISEASE SEVERITY; DRUG APPROVAL; DRUG DESIGN; DRUG RESEARCH; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

EID: 84880763942     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003119     Document Type: Article

References (43)

1. Lazarou J, Pomeranz BH, Corey PN, (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279: 1200-1205.
2. Giacomini KM, Krauss RM, Roden DM, Eichelbaum M, Hayden MR, et al. (2007) When good drugs go bad. Nature 446: 975-977.
3. Allison M, (2012) Reinventing clinical trials. Nat Biotechnol 30: 41-49.
4. Xie L, Kinnings SL, Bourne PE, (2012) Novel computational approaches to polypharmacology as a means to define responses to individual drugs. Annu Rev Pharmacol Toxicol 52: 361-379.
5. Pauwels E, Stoven V, Yamanishi Y, (2011) Predicting drug side-effect profiles: a chemical fragment-based approach. BMC Bioinformatics 12: 169.
6. Krejsa CM, Horvath D, Rogalski SL, Penzotti JE, Mao B, et al. (2003) Predicting ADME properties and side effects: the BioPrint approach. Curr Opin Drug Discov Devel 6: 470-480.
7. Fraunfelder FW, (2005) Visual side effects associated with erectile dysfunction agents. Am J Ophthalmol 140: 723-724.
8. Ellis C, (2003) FDA alerts asthmatics to drug safety risk. Nat Rev Drug Discov 2: 765.
9. Barabasi AL, Gulbahce N, Loscalzo J, (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12: 56-68.
10. Hopkins AL, (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4: 682-690.
11. Wang X, Gulbahce N, Yu H, (2011) Network-based methods for human disease gene prediction. Brief Funct Genomics 10: 280-293.
12. Wang X, Wei X, Thijssen B, Das J, Lipkin SM, et al. (2012) Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol 30: 159-164.
13. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P, (2008) Drug target identification using side-effect similarity. Science 321: 263-266.
14. Brouwers L, Iskar M, Zeller G, van Noort V, Bork P, (2011) Network neighbors of drug targets contribute to drug side-effect similarity. PLoS One 6: e22187.
15. Hase T, Tanaka H, Suzuki Y, Nakagawa S, Kitano H, (2009) Structure of protein interaction networks and their implications on drug design. PLoS Comput Biol 5: e1000550.
16. Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P, (2010) A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 6: 343.
17. Knox C, Law V, Jewison T, Liu P, Ly S, et al. (2011) DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 39: D1035-1041.
18. Vidal M, Cusick ME, Barabasi AL, (2011) Interactome networks and human disease. Cell 144: 986-998.
19. Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M, (2007) The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol 3: e59.
20. Kim PM, Lu LJ, Xia Y, Gerstein MB, (2006) Relating three-dimensional structures to protein networks provides evolutionary insights. Science 314: 1938-1941.
21. Lounkine E, Keiser MJ, Whitebread S, Mikhailov D, Hamon J, et al. (2012) Large-scale prediction and testing of drug activity on side-effect targets. Nature 486: 361-367.
22. Knight ZA, Lin H, Shokat KM, (2010) Targeting the cancer kinome through polypharmacology. Nat Rev Cancer 10: 130-137.
23. Schaefer MH, Fontaine JF, Vinayagam A, Porras P, Wanker EE, et al. (2012) HIPPIE: Integrating protein interaction networks with experiment based quality scores. PLoS One 7: e31826.
24. Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, et al. (2009) PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res 37: W623-633.
25. Rask-Andersen M, Almen MS, Schioth HB, (2011) Trends in the exploitation of novel drug targets. Nat Rev Drug Discov 10: 579-590.
26. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human disease network. Proc Natl Acad Sci USA 104: 8685-8690.
27. Silva JM, Marran K, Parker JS, Silva J, Golding M, et al. (2008) Profiling essential genes in human mammary cells by multiplex RNAi screening. Science 319: 617-620.
28. Yu H, Tardivo L, Tam S, Weiner E, Gebreab F, et al. (2011) Next-generation sequencing to generate interactome datasets. Nat Methods 8: 478-480.
29. Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, et al. (2009) An empirical framework for binary interactome mapping. Nat Methods 6: 83-90.
30. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, et al. (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122: 957-968.
31. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, et al. (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437: 1173-1178.
32. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human Protein Reference Database-2009 update. Nucleic Acids Res 37: D767-772.
33. Breitkreutz BJ, Stark C, Reguly T, Boucher L, Breitkreutz A, et al. (2008) The BioGRID Interaction Database: 2008 update. Nucleic Acids Res 36: D637-640.
34. Aranda B, Achuthan P, Alam-Faruque Y, Armean I, Bridge A, et al. (2010) The IntAct molecular interaction database in 2010. Nucleic Acids Res 38: D525-531.
35. Ceol A, Chatr Aryamontri A, Licata L, Peluso D, Briganti L, et al. (2010) MINT, the molecular interaction database: 2009 update. Nucleic Acids Res 38: D532-539.
36. Hu Z, Hung JH, Wang Y, Chang YC, Huang CL, et al. (2009) VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology. Nucleic Acids Res 37: W115-121.
37. Turner B, Razick S, Turinsky AL, Vlasblom J, Crowdy EK, et al. (2010) iRefWeb: interactive analysis of consolidated protein interaction data and their supporting evidence. Database (Oxford) 2010: baq023.
38. Cusick ME, Yu H, Smolyar A, Venkatesan K, Carvunis AR, et al. (2009) Literature-curated protein interaction datasets. Nat Methods 6: 39-46.
39. Turinsky AL, Razick S, Turner B, Donaldson IM, Wodak SJ, (2010) Literature curation of protein interactions: measuring agreement across major public databases. Database (Oxford) 2010: baq026.
40. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic Acids Res 28: 235-242.
41. Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, et al. (2009) The Human Gene Mutation Database: 2008 update. Genome Med 1: 13.
42. Amberger J, Bocchini CA, Scott AF, Hamosh A, (2009) McKusick's Online Mendelian Inheritance in Man (OMIM). Nucleic Acids Res 37: D793-796.
43. Tan P-N, Steinbach M, Kumar V (2006) Introduction to data mining. Boston: Pearson Addison Wesley. xxi, 769 pp.